JACC. Case reports · 2026
Acute Myocardial Infarction in an Intermediate-Risk Patient: Implications for Cardiovascular Risk Stratification.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Akinmolayemi Oludamilola, Vasa Devarshi, Bhatt Deepak L
Аннотация
BACKGROUND: Cardiovascular risk stratification is essential and informative for long-term prognostication. However, it is often limited by heterogeneous patient profiles.
CASE SUMMARY: An asymptomatic 76-year-old man with a history of multiple myeloma in remission presented for cardiovascular risk assessment. Despite intermediate-risk classification of atherosclerotic cardiovascular disease using risk stratification scores, the coronary artery calcium score (73 Agatston units) was used to guide decision-making regarding initiation of lipid-lowering therapy. However, before therapy initiation, the patient experienced an ST-segment elevation myocardial infarction.
DISCUSSION: Cardiovascular risk stratification tools serve an important role in evaluating patient risk and facilitating shared decision-making in clinical management. Nonetheless, these tools present certain limitations in predicting comprehensive risk outcomes, especially when used independently.
KEY TAKEAWAYS: This case highlights the intricacies associated with cardiovascular risk stratification tools and reinforces the importance of using a multimodal assessment strategy to inform the initiation of preventive therapies.
CASE SUMMARY: An asymptomatic 76-year-old man with a history of multiple myeloma in remission presented for cardiovascular risk assessment. Despite intermediate-risk classification of atherosclerotic cardiovascular disease using risk stratification scores, the coronary artery calcium score (73 Agatston units) was used to guide decision-making regarding initiation of lipid-lowering therapy. However, before therapy initiation, the patient experienced an ST-segment elevation myocardial infarction.
DISCUSSION: Cardiovascular risk stratification tools serve an important role in evaluating patient risk and facilitating shared decision-making in clinical management. Nonetheless, these tools present certain limitations in predicting comprehensive risk outcomes, especially when used independently.
KEY TAKEAWAYS: This case highlights the intricacies associated with cardiovascular risk stratification tools and reinforces the importance of using a multimodal assessment strategy to inform the initiation of preventive therapies.